I’ve been building in tech, cyber, privacy, and clinical data for 25+ years across Israeli medical device startups, Verily, Amgen, and the Fortune 1 company. I work at the intersection of engineering, regulatory risk and clinical data — helping teams produce cost-effective, prioritized security countermeasure plans.

I help you turn cyber and privacy risk into shorter sales cycles and higher prices..

Most companies treat cyber and privacy risk as paperwork instead of a quantitative system.

This is the #1 anti-pattern behind failed FDA submissions. My practical threat analysis system eliminates that anti-pattern. I help teams produce cybersecurity packages that are clear, logically complete, traceable, and aligned with the 2025 FDA Cybersecurity Guidance and Section 524B.

I am the Cyber & Privacy Advisor for WHO Europe. I work across global digital health, safety, and regulatory risk — experience that directly informs my structured, outcome-focused approach.

What I Deliver

• FDA-aligned threat modeling
• Cyber risk analysis based on quantitative models
• Prioritized, cost-effective countermeasure plans
• SBOM review + vulnerability-management strategy
• Submission-ready cybersecurity documentation
• Traceability (threat → risk → mitigation → residual risk)
• Training so your team can “run with the ball”
• Fixed-price, no surprises

Who I Work With

• Medical-device manufacturers
• Digital health companies
• Digital therapeutics companies
• AI-diagnostic teams
• Healthtech companies
• RA/QA preparing premarket submissions
• CTOs preparing for regulatory scrutiny
• CEOs who want to know how much money is on the table.

Why Teams Choose Me

• Clear, regulator-ready outputs
• Outcome-based fixed pricing
• System-level thinking
• Quantitative models of your device business instead of regulatory checklists

If you want to reduce deal friction or raise your prices, grab a slot below. —